A Study of an Implantable Miniature Telescope in Patients With With End-Stage AMD

NCT00555165 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2012-11-14

No results posted yet for this study

Summary

Evaluation of pre and post-implantation management of patients with end-stage age-related macular degeneration (AMD) who have been implanted with the implantable telescope (IMT) under CE Mark indicated use. This study is designed to evaluate in particular the optimal parameters for patient selection for use of this device in routine clinical practice.

Conditions

  • End Stage Macular Degeneration

Interventions

DEVICE

Telescope prosthesis

Monocular implantation of the telescope prosthesis after cataract extraction

Sponsors & Collaborators

  • VisionCare, Inc.

    lead INDUSTRY

Principal Investigators

  • Giuliana Silvestri, MD FRCP FRCS · Royal Hospitals, Belfast Health & Social Care Trust

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00555165 on ClinicalTrials.gov